Carregant…
Brain Tumor Immunotherapy: What have We Learned so Far?
High grade glioma is a rare brain cancer, incurable in spite of modern neurosurgery, radiotherapy, and chemotherapy. Novel approaches are in research, and immunotherapy emerges as a promising strategy. Clinical experiences with active specific immunotherapy demonstrate feasibility, safety and most i...
| Autor principal: | |
|---|---|
| Format: | Online Article Text |
| Idioma: | English |
| Publicat: |
Frontiers Media S.A.
2015
|
| Matèries: | |
| Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470276/ https://www.ncbi.nlm.nih.gov/pubmed/26137448 http://dx.doi.org/10.3389/fonc.2015.00098 |